| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.009 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |